1. Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial*: 达格列净治疗接受二甲双胍治疗失败的亚洲2型糖尿病患者的疗效和安全性:一项随机对照研究. (9th January 2016) Authors: Yang, Wenying; Han, Ping; Min, Kyung‐Wan; Wang, Bei; Mansfield, Traci; T'Joen, Caroline; Iqbal, Nayyar; Johnsson, Eva; Ptaszynska, Agata Journal: Journal of diabetes Issue: Volume 8:Number 6(2016:Nov.) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double‐blind, active‐controlled, phase 3 trial. Issue 3 (26th October 2017) Authors: Dou, Jingtao; Ma, Jianhua; Liu, Jun; Wang, Changjiang; Johnsson, Eva; Yao, Hui; Zhao, June; Pan, Changyu Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 3(2018) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes. Issue 11 (16th July 2018) Authors: Müller‐Wieland, Dirk; Kellerer, Monika; Cypryk, Katarzyna; Skripova, Dasa; Rohwedder, Katja; Johnsson, Eva; Garcia‐Sanchez, Ricardo; Kurlyandskaya, Raisa; Sjöström, C. David; Jacob, Stephan; Seufert, Jochen; Dronamraju, Nalina; Csomós, Katalin Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 11(2018) Page Start: 2598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SP262THE IMPACT OF URATE-LOWERING DRUGS VERINURAD AND FEBUXOSTAT ON ALBUMINURIA IN TYPE 2 DIABETES. (13th June 2019) Authors: Stack, Austin; Dronamraju, Nalina; Parkinson, Joanna; Johansson, Susanne; Johnsson, Eva; Erlandsson, Fredrik; Terkeltaub, Robert Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Issue 1 (26th September 2016) Authors: Lundkvist, Per; Sjöström, C. David; Amini, Sam; Pereira, Maria J.; Johnsson, Eva; Eriksson, Jan W. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 1(2017) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Issue 9 (31st May 2017) Authors: Lundkvist, Per; Pereira, Maria J.; Katsogiannos, Petros; Sjöström, C. David; Johnsson, Eva; Eriksson, Jan W. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 9(2017) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Metformin extended‐release versus immediate‐release: An international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes. Issue 2 (2nd October 2017) Authors: Aggarwal, Naresh; Singla, Anuj; Mathieu, Chantal; Montanya, Eduard; Pfeiffer, Andreas F. H.; Johnsson, Eva; Zhao, June; Iqbal, Nayyar; Bailey, Clifford Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 2(2018) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cover Image, Volume 22, Issue 7. Issue 7 (19th June 2020) Authors: Johansson, Lars; Hockings, Paul D.; Johnsson, Eva; Dronamraju, Nalina; Maaske, Jill; Garcia‐Sanchez, Ricardo; Wilding, John P. H. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 7(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial. Issue 7 (9th March 2020) Authors: Frias, Juan P.; Gonzalez‐Galvez, Guillermo; Johnsson, Eva; Maaske, Jill; Testa, Marcia A.; Simonson, Donald C.; Dronamraju, Nalina; Garcia‐Sanchez, Ricardo; Peters, Anne L. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 7(2020) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes. Issue 7 (9th March 2020) Authors: Johansson, Lars; Hockings, Paul D.; Johnsson, Eva; Dronamraju, Nalina; Maaske, Jill; Garcia‐Sanchez, Ricardo; Wilding, John P. H. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 7(2020) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗